Connection
Matthew McLaughlin to Neuromuscular Agents
This is a "connection" page, showing publications Matthew McLaughlin has written about Neuromuscular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.717 |
|
|
|
-
McLaughlin MJ, Fisher MT, Vadivelu S, Ramsey J, Ratnasingam D, McGhee E, Hartman K. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19). J Pediatr Rehabil Med. 2020; 13(3):273-279.
Score: 0.717